文献速递哮喘睡眠呼吸障碍

持续气道正压通气未改善哮喘控制

Continuous positive airway pressure for obstructive sleep apnoea does not improve asthma control.
PubMed 文献 · Respirology · 2018-07-10

本研究在夜间哮喘症状且打鼾患者中筛查阻塞性睡眠呼吸暂停综合征(OSAS),将AHI≥10/h者随机分为CPAP组和保守治疗组治疗3个月。结果显示CPAP未显著改善哮喘控制测试评分,但改善了日间嗜睡、哮喘生活质量和活力。

要点

  • 哮喘伴打鼾者OSAS患病率较高,33.6%患者AHI≥10/h
  • CPAP治疗3个月未显著改善哮喘控制(ACT评分差异无统计学意义)
  • CPAP可改善日间嗜睡、哮喘生活质量和SF-36活力域

核心结论

  • 在哮喘伴打鼾患者中OSAS患病率较高,CPAP治疗3个月未增强哮喘控制但改善了日间嗜睡、生活质量和活力。

研究设计与样本

  • 随机对照试验,145例招募,122例完成睡眠研究,41例(33.6%)AHI≥10/h,37例纳入意向性分析(CPAP组17例,对照组20例),治疗3个月。

主要发现

  • 显著OSAS患者BMI更高(27.4 (5.1) vs 25.1 (4.5) kg/m2,P=0.016),颈围更大(36.6 (3.1) vs 34.8 (3.6) cm,P=0.006),最低SaO2更低(80.7 (6.6) vs 87.2 (3.9)%,P<0.001)。
  • CPAP组与对照组ACT评分差异无统计学意义(3.2 (2.7) vs 2.4 (5.7),P=0.568)。
  • CPAP组Epworth嗜睡量表改善更显著(-3.0 (4.5) vs 0.5 (3.8),P=0.014)。
  • CPAP组哮喘生活质量问卷改善更显著(0.6 (0.8) vs 0.02 (0.7),P=0.022)。
  • CPAP组SF-36活力域改善更显著(14.7 (16.8) vs 0.3 (16.2),P=0.012)。

临床怎么用

  • 对夜间哮喘症状且打鼾的患者应考虑筛查OSAS,CPAP治疗可能改善日间嗜睡和生活质量,但不应期望显著改善哮喘控制。

局限性

  • 样本量较小(意向性分析37例),可能影响统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Unrecognized obstructive sleep apnoea syndrome (OSAS) may lead to poor asthma control despite optimal therapy. We assessed asthma control, airway responsiveness, daytime sleepiness and health status at baseline and 3 months after continuous positive airway pressure (CPAP) treatment among asthma patients with nocturnal symptoms and OSAS. METHODS: Patients with nocturnal asthma symptoms despite receiving at least moderate-dose inhaled corticosteroid and long-acting bronchodilators underwent a home sleep study using 'Embletta' portable diagnostic system. Patients with significant OSAS (apnoea-hypopnoea index (AHI) ≥10/h) were randomized to receive either CPAP or conservative treatment for 3 months. RESULTS: Among 145 patients recruited, 122 underwent sleep study with 41 (33.6%) having AHI ≥10/h. Patients with significant OSAS had higher BMI (27.4 (5.1) vs 25.1 (4.5) kg/m2 , P = 0.016), bigger neck circumference (36.6 (3.1) vs 34.8 (3.6) cm, P = 0.006) and lower minimum SaO2 (80.7 (6.6) vs 87.2 (3.9) %, P < 0.001). Using intention-to-treat analysis among 37 patients with AHI ≥10/h (CPAP group (n = 17) vs control group (n = 20)), there was no significant difference in Asthma Control Test score (CPAP 3.2 (2.7) vs control 2.4 (5.7), P = 0.568) but the CPAP group had a greater improvement in Epworth Sleepiness Scale (-3.0 (4.5) vs 0.5(3.8), P = 0.014), Asthma Quality of Life Questionnaire (0.6 (0.8) vs 0.02 (0.7), P = 0.022) and vitality domain in the SF-36 questionnaire (14.7 (16.8) vs 0.3 (16.2), P = 0.012) after 3 months. Data are presented as mean (SD) unless otherwise stated. CONCLUSION: A high prevalence of OSAS was found among patients with asthma and snoring. CPAP therapy for 3 months did not enhance asthma control but improved daytime sleepiness, quality of life and vitality.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Ng SSS, Chan TO, To KW, et al. Continuous positive airway pressure for obstructive sleep apnoea does not improve asthma control. Respirology. 2018. PMID: 29992713. doi:10.1111/resp.13363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。